Biobanking and the future of sample handling

Biobanking is of central importance for personalized medicine, pathology and in drug discovery. It allows researchers to manage biological sample collections in an accessible repository both effectively and easily.

The numerous benefits of a centralized biobank for studies focused on particular conditions or for wider, more general research.

Exploring the scale of modern biobanking

Biobanking is heavily relied upon by many areas of human genetics research to store samples of biological specimens from hundreds of thousands of participants.

The UK Biobank project explores the link between major disease development and various lifestyle, environmental and genetic factors. This project requires considerable sample and data collection from as many as 500,000 participants.

The Zhangjian Biobank in Shanghai has reportedly reached a storage capacity of 10 million samples and Helmholz Biobank in Munich, Germany contains many millions of samples.

The need for ethical and efficient storage protocols for dealing with human-derived samples takes on a new meaning at such enormous scales. However, these huge biobanks are not the only places that need to implement storage protocols for smart biorepository.

All pharmaceutical and biotech companies running biobank research should develop a sound and thorough system for sample and information management.

Appropriate sample handling

Both data loss and insufficient sample documentation can devastate research initiatives and force researchers to repeat experiments. This can significantly drain resources and time. Therefore, appropriately managing and controlling biobanking information is crucial.

Ziath specializes in both instrumentation control and information management with a focus on large sample libraries using 2D datamatrix tubes. A wide range of specimen types are supported by global biobanks, including body fluids (plasma, serum, urine, extracted DNA, etc.), biopsies and more.

The feasibility of samples is typically preserved at cryogenic temperatures through the use of tubes with high-integrity closures. 2D barcoding of each sample tube guarantees full traceability, optionally in addition to the manufactured linear barcode printed onto the side of each tube.

Having absolute integrity for these storage protocols guarantees that all sample information can, whenever necessary, be quickly recalled. By combining 2D barcoded cryotubes with proprietary information management software samples and 2D tube rack reachers, Ziath allows researchers to store all relevant data accessibly and easily.

Additionally, Ziath products can be used with any tubes and our tubes can be used with any scanners because they will interact with other items. The company’s aim is to maximize the scientific return for biobank researchers streamline workflows within the parameters of the organizations’ individual budgets and timeframes.

This helps assist with individual diagnoses in emerging areas of personalized medicine or accelerate times to market for novel therapeutics.

About Ziath LtdZiath Logo

Ziath specializes in instrumentation control and information management in both the academic and the pharmaceutical/biotech industry sectors with a focus on the application of laboratory automation. In particular, we focus on managing large sample libraries (compound management, biobanking and sample management) using 2D datamatrix tubes.

Founded in 2005 by scientists and engineers; Ziath is over a decade old and is proud to server customers across the world. Ziath develops innovative new products designed to simplify processes in life science organizations. In addition Ziath offers consulting and contracting work to clients.

Ziath has a range of products split into four main categories of 2D barcode scanners, devices for handling tubes, 2D barcoded tubes and sample management software.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Last updated: Sep 14, 2021 at 5:36 AM

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Ziath Ltd. (2021, September 14). Biobanking and the future of sample handling. News-Medical. Retrieved on September 21, 2021 from https://www.news-medical.net/whitepaper/20210903/Biobanking-and-the-future-of-sample-handling.aspx.

  • MLA

    Ziath Ltd. "Biobanking and the future of sample handling". News-Medical. 21 September 2021. <https://www.news-medical.net/whitepaper/20210903/Biobanking-and-the-future-of-sample-handling.aspx>.

  • Chicago

    Ziath Ltd. "Biobanking and the future of sample handling". News-Medical. https://www.news-medical.net/whitepaper/20210903/Biobanking-and-the-future-of-sample-handling.aspx. (accessed September 21, 2021).

  • Harvard

    Ziath Ltd. 2021. Biobanking and the future of sample handling. News-Medical, viewed 21 September 2021, https://www.news-medical.net/whitepaper/20210903/Biobanking-and-the-future-of-sample-handling.aspx.

Other White Papers by this Supplier